Report copyright - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · 3 Bevacizumab, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment
Please pass captcha verification before submit form